Japan News
-
Hitachi to provide CNAO with Proton Therapy System
Japan | News | 0 Comment | 09 Dec, 2019
Japan headquartered Hitachi, Ltd. has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system. In the comprehensive public ten...Read more
-
BitBiome to analyse gut bacteria related to cancer
Japan | News | 0 Comment | 06 Dec, 2019
bitBiome, Inc., a start-up company from Waseda University in Japan, and National Cancer Center of Japan have signed a collaborative research agreement on the analysis of...Read more
-
Astellas to acquire Audentes Therapeutics in a $3B deal
Japan | News | 0 Comment | 03 Dec, 2019
Japan headquartered Astellas Pharma Inc. and Audentes Therapeutics, Inc. have entered into a definitive agreement for Astellas to acquire Audentes at a price of US$60.00 per share in cash, ...Read more
-
Chugai Pharma's study on satralizumab published in The New England Journal of Medicine
Japan | News | 0 Comment | 02 Dec, 2019
Chugai Pharmaceutical has announced that the "New England Journal of Medicine" (NEJM) online edition November 27 Results of the global phase III SAkuraSky clinical study (NCT02028884)...Read more
-
Fujitsu Labs, ACC to advance cancer genomic medicine
Japan | News | 0 Comment | 02 Dec, 2019
Japan based Fujitsu Laboratories Ltd. and Aichi Cancer Center (ACC) have successfully concluded a comprehensive cooperative research agreement to leverage newly developed AI technology to i...Read more
-
Ono Pharma seeks Japanese approval for tirabrutinib
Japan | News | 0 Comment | 28 Nov, 2019
Japan based Ono Pharmaceutical Co., Ltd. has announced that ONO submitted an application of tirabrutinib hydrochloride (ONO-4059) (“Tirabrutinib”), a Bruton’s tyrosine kin...Read more
-
ONO Submits Supplemental Application for additional Opdivo®
Japan | News | 0 Comment | 28 Nov, 2019
Intravenous Infusion Monotherapy Dosage and Schedule in Japan Ono Pharmaceutical Co., Ltd. has announced that ONO submitted a supplemental application for a partial change in the approved i...Read more
-
Hitachi develops automation technology of 3D culture
Japan | News | 0 Comment | 29 Nov, 2019
Hitachi, Ltd. headquartered in Tokyo, Japan, is focusing on Social Innovation Business combining its operational technology, information technology and products, has developed a new automat...Read more
-
Ardelyx and Kyowa Kirin expand partnership
Japan | News | 0 Comment | 28 Nov, 2019
US based Ardelyx, Inc., a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment for people with cardiorenal diseases and Kyowa Kirin Co.,...Read more
-
Asahi Kasei collaborates with Woolsey Pharma
Japan | News | 0 Comment | 27 Nov, 2019
US based Woolsey Pharmaceuticals has announced that it has completed a license agreement with Japanese pharmaceutical company Asahi Kasei Pharma Corporation, for rights to its drug, fasudil...Read more
-
Eisai Launches First Amazon Alexa Skill Designed for Epileptic Children
Japan | News | 0 Comment | 26 Nov, 2019
Eisai Inc., the U.S. subsidiary of Eisai Co., Ltd., has announced the launch of Ella the Jellyfish, the first Amazon Alexa skill designed for those affected by Lennox-Gastaut Syndrome...Read more
-
Shionogi receives FDA approval for cUTI drug
Japan | News | 0 Comment | 26 Nov, 2019
Japan based Shionogi & Co., Ltd. has announced the U.S. Food and Drug Administration (FDA) has approved FETROJA® (cefiderocol) for patients 18 years of age or older who have li...Read more
-
Eisai launches Parkinson's drug in Japan
Japan | News | 0 Comment | 25 Nov, 2019
Tokyo headquartered Eisai Co., Ltd. announced that it has launched the Equfina® 50mg TABLETS (safinamide mesilate, “Equfina”) for the indication of improvement of weari...Read more
-
Astellas and Welldoc collaborate for digital therapeutics
Japan | News | 0 Comment | 22 Nov, 2019
Japan headquartered Astellas Pharma Inc. and US based Welldoc, Inc. have entered into a collaboration and license agreement directed toward the development and commercialization of digital ...Read more
-
Japan grants ODD to Merck's investigational therapy Tepotinib
Japan | News | 0 Comment | 21 Nov, 2019
Merck, a leading science and technology company, has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted orphan drug designation (ODD) for its investigatio...Read more
-
Toray signs pact with JICA to support infection control capacity
Japan | News | 0 Comment | 20 Nov, 2019
Japan headquartered Toray Industries, Inc., has made an agreement with the Japan International Cooperation Agency (JICA) to undertake a project to promote deployment and utilization of Japa...Read more
-
Novartis to buy Aspen’s Japanese operations
Japan | News | 0 Comment | 18 Nov, 2019
Sandoz has announced that it has entered into a binding agreement for the planned acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly owned subsidiary of Aspen...Read more
-
Japan | News | 0 Comment | 18 Nov, 2019
Indian pharma major Lupin Limited (including its subsidiaries, together referred to as ‘Lupin’) announced that it has entered into a definitive agreement for the sale...Read more
